SERUM PSA AFTER ANATOMIC RADICAL PROSTATECTOMY

Abi-Aad, 1992, Detection of local recurrence after radical prostatectomy by prostate specific antigen and transrectal ultrasound, J Urol, 147, 952, 10.1016/S0022-5347(17)37431-1

Brawer, 1989, PSA in the screening, staging and follow-up of early-stage prostate cancer: A review of recent developments, World J Urol, 7, 7, 10.1007/BF01576837

Chodak, 1990, Effect of external beam radiation therapy on serum prostate-specific antigen, Urology, 35, 288, 10.1016/0090-4295(90)80147-F

Chu, 1986, What's new in tumor markers for prostate cancer, Urology, 27, 487, 10.1016/0090-4295(86)90324-9

Epstein, 1993, Correlation of pathologic findings with progression following radical retropubic prostatectomy, Cancer, 71, 10.1002/1097-0142(19930601)71:11<3582::AID-CNCR2820711120>3.0.CO;2-Y

Epstein, 1993, Influence of capsular penetration on progression following radical prostatectomy: A study of 196 cases with long-term follow-up, J Urol, 150, 135, 10.1016/S0022-5347(17)35415-0

Ercole, 1987, Prostate specific antigen and prostatic acid phosphatase in the monitoring and staging of patients with prostatic cancer, J Urol, 138, 1181, 10.1016/S0022-5347(17)43543-9

Goldrath, 1989, Prostate specific antigen: Not detectable despite tumor progression after radical prostatectomy, J Urol, 142, 1082, 10.1016/S0022-5347(17)38998-X

Hudson, 1989, Clinical use of prostate specific antigen in patients with prostate cancer, J Urol, 142, 1011, 10.1016/S0022-5347(17)38972-3

Kabalin, 1989, Identification of residual cancer in the prostate following radiation therapy: Role of transrectal ultrasound guided biopsy and prostate specific antigen, J Urol, 142, 326, 10.1016/S0022-5347(17)38746-3

Kaplan, 1958, Nonparametric estimation from incomplete observations, J Am Stat Assoc, 53, 10.1080/01621459.1958.10501452

Kaplan, 1990, Prostate specific antigen after irradiation for prostatic carcinoma, J Urol, 144, 1172, 10.1016/S0022-5347(17)39684-2

Killian, 1985, Prognostic importance of PSA for monitoring patients with stages B2 to D1 prostate cancer, Cancer Res, 45, 886

Lange, 1989, The value of serum prostate specific antigen determinations before and after radical prostatectomy, J Urol, 141, 10.1016/S0022-5347(17)41037-8

Lange, 1990, The effect of radiation therapy after radical prostatectomy in patients with elevated prostate specific antigen levels, J Urol, 144, 927, 10.1016/S0022-5347(17)39624-6

Lightner, 1990, Prostate specific antigen and local recurrence after radical prostatectomy, J Urol, 144, 921, 10.1016/S0022-5347(17)39623-4

Link, 1991, Adjuvant radiation therapy in patients with detectable prostate specific antigen following radical prostatectomy, J Urol, 145, 532, 10.1016/S0022-5347(17)38388-X

Morgan, 1991, Prostate specific antigen values after radical retropubic prostatectomy for adenocarcinoma of the prostate: Impact of adjuvant treatment (hormonal and radiation), J Urol, 145, 319, 10.1016/S0022-5347(17)38327-1

Morton, 1991, Cancer control following anatomical radical prostatectomy: An interim report, J Urol, 145, 1197, 10.1016/S0022-5347(17)38574-9

Oesterling, 1991, Prostate specific antigen: A critical assessment of the most useful tumor marker for adenocarcinoma of the prostate, J Urol, 145, 907, 10.1016/S0022-5347(17)38491-4

Oesterling, 1988, Prostate specific antigen in the preoperative and postoperative evaluation of localized prostatic cancer treated with radical prostatectomy, J Urol, 139, 766, 10.1016/S0022-5347(17)42630-9

Partin, 1993, Impact of capsular penetration on prognosis in men with clinically localized prostate cancer, J Urol, 150, 142, 10.1016/S0022-5347(17)35416-2

Partin, 1990, Prostate specific antigen in the staging of localized prostate cancer: Influence of tumor differentiation, tumor volume and benign hyperplasia, J Urol, 143, 747, 10.1016/S0022-5347(17)40079-6

Rainwater, 1990, Prostate-specific antigen testing in untreated and treated prostatic adenocarcinoma, Mayo Clin Proc, 65, 10.1016/S0025-6196(12)62725-6

Schellhammer, 1991, Prostate specific antigen levels after definitive irradiation for carcinoma of the prostate, J Urol, 145, 1008, 10.1016/S0022-5347(17)38514-2

Schild, 1992, The results of radiotherapy for isolated elevation of serum PSA levels following radical prostatectomy, Int J Radiat Oncol Biol Phys, 23, 141, 10.1016/0360-3016(92)90553-T

Schröder, 1992, The TNM classification of prostate cancer, Prostate, 4, 129, 10.1002/pros.2990210521

Stamey, 1989, Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate III: Radiation treated patients, J Urol, 141, 1084, 10.1016/S0022-5347(17)41176-1

Stamey, 1989, Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate IV: Anti-androgen treated patients, J Urol, 141, 1088, 10.1016/S0022-5347(17)41177-3

Stamey, 1989, Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate II: Radical prostatectomy treated patients, J Urol, 141, 1076, 10.1016/S0022-5347(17)41175-X

Stamey, 1987, Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate, N Engl J Med, 317, 909, 10.1056/NEJM198710083171501

Stein, 1991, Prostatic specific antigen related to clinical status 1 to 14 years after radical retropubic prostatectomy, Br J Urol, 67, 626, 10.1111/j.1464-410X.1991.tb15228.x

Stein, 1992, Prostate specific antigen levels after radical prostatectomy in patients with organ confined and locally extensive prostate cancer, J Urol, 147, 942, 10.1016/S0022-5347(17)37429-3

Steinberg, 1990, Radical prostatectomy expanding role in the management of patients with adenocarcinoma of the prostate, Prob Urol, 4

Takayama, 1992, Recurrent prostate cancer despite undetectable prostate specific antigen, J Urol, 148, 1541, 10.1016/S0022-5347(17)36963-X

Walsh, 1988, Nerve sparing radical prostatectomy for early stage prostate cancer, Semin Oncol, 15, 351

Walsh, 1988, Radical retropubic prostatectomy with reduced morbidity: An anatomic approach, NCI Monogr, 7, 133

Walsh, 1982, Impotence following radical prostatectomy: Insight into etiology and prevention, J Urol, 128, 492, 10.1016/S0022-5347(17)53012-8

Zagars, 1991, Prostate-specific antigen and external beam radiation therapy in prostate cancer, Cancer, 67, 412, 10.1002/1097-0142(19910115)67:2<412::AID-CNCR2820670216>3.0.CO;2-R

Zincke, 1992, Stage Dl prostate cancer treated by radical prostatectomy and adjuvant hormonal treatment, Cancer, 70, 311, 10.1002/1097-0142(19920701)70:1+<311::AID-CNCR2820701320>3.0.CO;2-T